Table 5.
CMR findings EGPA
| Controls (n = 20) | Patients (n = 22) | p | |
|---|---|---|---|
| LV-EF (%) | 65 ± 4 | 62 ± 12 | 0.58 |
| LV-EDV (ml) | 109 ± 27 | 124 ± 48 | 0.38 |
| LV-ESV (ml) | 38 ± 13 | 51 ± 37 | 0.35 |
| LV-SV | 71 ± 15 | 74 ± 17 | 0.76 |
| LV-EDD | 45 ± 5 | 48 ± 6 | 0.06 |
| LA (cm2) | 20 ± 3 | 21 ± 6 | 0.97 |
| IVS (mm) | 10 ± 2 | 10 ± 2 | 0.23 |
| PA (mm) | 24 ± 4 | 25 ± 3 | 0.27 |
| LV mass (g) | 85 ± 20 | 89 ± 25 | 0.83 |
| LGE per patient | - | 9 (41%) | |
| epicardial | - | 3 (14%) | |
| intramural | - | 2 (9%) | |
| transmural | - | - | |
| subendocardial | - | 4 (18%) | |
| % LV mass | - | 7.1 ± 6 | |
| Native T1 (ms) | 952 (923–960) | 982 (958–1007) | 0.003 |
| Post-contrast T1 (ms) | 524 (500–529) | 481 (462–527) | 0.02 |
| ECV (%) | 24.5 (23–25) | 28 (25–31) | <0.001 |
| T2 (ms) | 49 (48–51) | 53 (50–55) | <0.001 |
All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume